Tomoh Masaki

Title: The Innovations of Tomoh Masaki

Introduction

Tomoh Masaki is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of endothelin proteins. With a total of 5 patents to his name, Masaki's work has implications for therapeutic applications in medicine.

Latest Patents

Masaki's latest patents include groundbreaking research on DNA encoding human endothelin-3. This patent discloses a cloned DNA molecule that encodes a human endothelin-3 protein with a specific amino acid sequence. The method described allows for the production of mature endothelin-3 protein by culturing host cells, leading to its accumulation in the culture medium. Another significant patent involves the human endothelin-3 precursor protein, which includes a DNA sequence coding for endothelin-2 or human endothelin-3. This innovation enables the advantageous production of these proteins, which can be utilized as hypotension therapeutic agents or local vasoconstrictors.

Career Highlights

Throughout his career, Tomoh Masaki has worked with notable companies such as Takeda Chemical Industries, Inc. and Takeda Chemical Ind., Ltd. His work in these organizations has allowed him to advance his research and contribute to the development of important medical therapies.

Collaborations

Masaki has collaborated with esteemed colleagues, including Masashi Yanagisawa and Akihiro Inoue. These partnerships have further enriched his research and innovation in the field of biotechnology.

Conclusion

Tomoh Masaki's contributions to the field of biotechnology, particularly through his patents on endothelin proteins, highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in medicine.